Navigation Links
AquaLiv Technologies Subsidiary AquaLiv, Inc. Discusses Registration In Kenya Concerning Its HIV/AIDS Treatment
Date:10/31/2011

SEATTLE, Oct. 31, 2011 /PRNewswire/ -- AquaLiv Technologies (OTCBB: AQLV) subsidiary, AquaLiv, Inc., discusses alternative medicine registration in Kenya for their NatuRx™ HIV/AIDS treatment.

The company previously announced that Kenyan officials recommend they register NatuRx™ HIV/AIDS as an alternative medicine treatment and that approval could be granted within 30-60 days.

"The process isn't quite as simple as it was explained to us," stated AquaLiv CEO, Craig Hoffman. "It isn't just the treatment that is being registered. Registration also requires completed retail packaging and inspection of a manufacturing facility that complies with cGMP (Current Good Manufacturing Practices) regulation. We wanted to simply get approval for the treatment, but that just isn't possible without the manufacturing component in place."

Mr. Hoffman continued, "We are looking for a manufacturing partner that could eventually supply the treatment to all African countries and we have identified some candidates in both Kenya and India. The big question for us right now is do we sign on with a partner capable of manufacturing our treatment as a liquid solution, as we do now in our laboratory, or should we wait until we have modified the treatment to be delivered in tablet form. We're closer than ever to being able to deliver all NatuRx™ treatments in tablet form and we think we will know definitively before the end of our planned clinical trial, which is when we would actually begin sales of the product."

The company further explained that tablets are more economical to distribute and will require fewer manufacturing partners overall.

"We're confident we will have the manufacturing issues worked out before the end of the trial," added Bill Wright, CEO of AquaLiv Technologies. "However, we communicated to our investors that an alternative medicine registration could be granted around this time and felt it was important to give investors an update."

Based on AquaLiv's patented BioT™ Bioinformation Technology, NatuRx™ formulations utilize novel wave-based information composites in lieu of molecules for treatment.

For more information about AquaLiv, visit their website: http://www.aqualiv.net

About AquaLiv Technologies, Inc.:

AquaLiv Technologies, Inc., through its subsidiaries, offers unique solutions and applications for a variety of industries and emerging technologies.

AquaLiv, Inc. is a life sciences research and development company creating novel products for numerous industries. The company's patented technology alters the behavior of organisms, including plants and humans, without chemical interaction. From increased crop yields to drug-free medicine, AquaLiv is providing innovative, ingredient-free solutions to the world's largest problems. To learn more about AquaLiv, please visit: www.aqualiv.net.

Safe Harbor: Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

Contact:
AquaLiv Technologies, Inc.
360-536-4220


'/>"/>
SOURCE AquaLiv Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
2. Connectyx Technologies to Host Teleconference on Third Quarter Financial Results on Tuesday November 15, 2011
3. Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics
4. China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Companys Convertible Notes in August 2008
5. Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Womens Health Technologies at the Journees Francaises de Radiologie (JFR)
6. SPX to Acquire e&e, a Global Supplier of Extraction, Evaporation, Vacuum and Freeze Drying Technologies
7. MedClean Technologies Partners With Triumvirate Environmental
8. goBalto Raises Series A Financing to Advance Cloud-based Health Technologies
9. New Clinical Studies Presented at the American Society of Anesthesiologists Annual Meeting Show Benefits of Masimo Noninvasive Technologies: SpHb, PVI, RRa, and SEDLine
10. Flow Cytometry: Products, Technologies and Global Markets
11. Ion Torrent CEO Jonathan Rothberg, Life Technologies Recognized by Wall Street Journal Technology Innovation Awards for the Ion Personal Genome Machine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Alkermes PLC ... AMAG ), IDEXX Laboratories Inc. (NASDAQ: IDXX ... Learn more about these stocks by accessing their free trade ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... To ... infrastructure. Most providers, however, are unsure how to move forward, given the need ... define a path forward tailored to an organization’s specific needs. , PYA Principal ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... SpiritQuest Sedona ... heart of West Sedona, surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, and ... partner properties – the Lodge at Sedona as well as the Sedona Rouge, both ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... An ... may expose a possible link between head and neck cancer in individuals with unhealthy ... the study were evaluated based on whether they had gum disease, brushed their teeth ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
Breaking Medicine News(10 mins):